80_FR_17502 80 FR 17440 - Advisory Council on Alzheimer's Research, Care, and Services; Meeting

80 FR 17440 - Advisory Council on Alzheimer's Research, Care, and Services; Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 62 (April 1, 2015)

Page Range17440-17441
FR Document2015-07374

This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer's Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people with the disease and their caregivers. During the April meeting, the Advisory Council will build on the goals of White House Conference on Aging (WHCOA) through a half- day session with dementia-focused panels on each WHCOA topic area: Healthy aging, long-term services and supports, retirement security, and elder justice. Following this session, the Advisory Council will also hold a brief discussion on the 2015 Update to the National Plan to Address Alzheimer's, as well as a discussion of international events on dementia.

Federal Register, Volume 80 Issue 62 (Wednesday, April 1, 2015) 
[Federal Register Volume 80, Number 62 (Wednesday, April 1, 2015)]
[Notices]
[Pages 17440-17441]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-07374]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council on Alzheimer's Research, Care, and Services 
provides advice on how to prevent or reduce the burden of Alzheimer's 
disease and related dementias on people with the disease and their 
caregivers. During the April meeting, the Advisory Council will build 
on the goals of White House Conference on Aging (WHCOA) through a half-
day session with dementia-focused panels on each WHCOA topic area: 
Healthy aging, long-term services and supports, retirement security, 
and elder justice. Following this session, the Advisory Council will 
also hold a brief discussion on the 2015 Update to the National Plan to 
Address Alzheimer's, as well as a discussion of international events on 
dementia.

DATES: The meeting will be held on April 28th, 2015 from 9:00 a.m. to 
5:00 p.m. EDT.

ADDRESSES: The meeting will be held in Room 800 in the Hubert H. 
Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201.
    Comments: Time is allocated in the afternoon on the agenda to hear 
public comments. The time for oral comments will be limited to two (2) 
minutes per individual. In lieu of oral comments, formal written 
comments may be submitted for the record to Rohini Khillan, OASPE, 200 
Independence Avenue SW., Room 424E, Washington, DC 20201. Comments may 
also be sent to napa@hhs.gov. Those submitting written comments should 
identify themselves and any relevant organizational affiliations.

FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932, 
rohini.khillan@hhs.gov. Note: Seating may be limited. Those wishing to 
attend the meeting must send an email to

[[Page 17441]]

napa@hhs.gov and put ``April 28 Meeting Attendance'' in the Subject 
line by Friday, April 17, so that their names may be put on a list of 
expected attendees and forwarded to the security officers at the 
Department of Health and Human Services. Any interested member of the 
public who is a non-U.S. citizen should include this information at the 
time of registration to ensure that the appropriate security procedure 
to gain entry to the building is carried out. Although the meeting is 
open to the public, procedures governing security and the entrance to 
Federal buildings may change without notice. If you wish to make a 
public comment, you must note that within your email.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: The Advisory Council will hear 
presentations on the basics of long-term care, including presentations 
on programs, settings, and payers. The Council will use a portion of 
the meeting to review the work it has accomplished thus far towards the 
2025 goals, and then discuss the process for developing recommendations 
for the 2015 update to the National Plan. The Council will also hear 
presentations from the three subcommittees (Research, Clinical Care, 
Long-Term Services and Supports, and Ethics).
    Procedure and Agenda: This meeting is open to the public. Please 
allow 30 minutes to go through security and walk to the meeting room. 
The meeting will also be webcast at www.hhs.gov/live.

    Authority:  42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of 
Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.

    Dated: March 25, 2015.
Richard G. Frank,
Assistant Secretary for Planning and Evaluation.
[FR Doc. 2015-07374 Filed 3-31-15; 8:45 am]
 BILLING CODE 4150-05-P

17440 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices general circumstances in which CDRH IV. Paperwork Reduction Act of 1995 DeviceRegulationandGuidance/ consults with a panel of the Medical GuidanceDocuments/ucm081363.htm. Devices Advisory Committee, the This guidance refers to previously Dated: March 26, 2015. process for exchange of information approved collections of information found in FDA regulations. These Leslie Kux, between CDRH, the members of the Associate Commissioner for Policy. panel, industry, and the public, and the collections of information are subject to conduct of panel meetings. The Medical review by the Office of Management and [FR Doc. 2015–07438 Filed 3–31–15; 8:45 am] Devices Advisory Committee includes Budget (OMB) under the Paperwork BILLING CODE 4164–01–P 17 panels other than the DRP (Ref. 1). Reduction Act of 1995 (44 U.S.C. 3501– The panels, according to their specialty 3520). The collections of information in 21 CFR part 807, subpart E have been DEPARTMENT OF HEALTH AND area and authorization, advise the HUMAN SERVICES Commissioner of Food and Drugs in approved under OMB control number discharging responsibilities as they 0910–0120; the collections of information in 21 CFR part 860 have Advisory Council on Alzheimer’s relate to assuring the safety and Research, Care, and Services; Meeting effectiveness of medical devices, and as been approved under OMB control required, any other product for which number 0910–0138; the collections of AGENCY: Assistant Secretary for FDA has regulatory responsibility. information in 21 CFR part 814 have Planning and Evaluation, HHS. This draft guidance is intended to been approved under OMB control ACTION: Notice of meeting. provide more comprehensive number 0910–0231; and the collections information for industry and for CDRH of information in 21 CFR part 814, SUMMARY: This notice announces the staff on the processes associated with a subpart H have been approved under public meeting of the Advisory Council panel meeting held for any of the OMB control number 0910–0332. on Alzheimer’s Research, Care, and reasons identified in the guidance. Once V. Comments Services (Advisory Council). The final, this guidance will replace the Advisory Council on Alzheimer’s ‘‘Guidance on Amended Procedures for Interested persons may submit either Research, Care, and Services provides Advisory Panel Meetings’’ (Ref. 2) and electronic comments regarding this advice on how to prevent or reduce the the guidance document entitled ‘‘Panel document to http://www.regulations.gov burden of Alzheimer’s disease and Review of Premarket Approval or written comments to the Division of related dementias on people with the Applications #P91–2 blue book memo’’ Dockets Management (see ADDRESSES). It disease and their caregivers. During the (Ref. 3). This guidance supplements is only necessary to send one set of April meeting, the Advisory Council existing FDA Agency-wide guidance on comments. Identify comments with the will build on the goals of White House the conduct of Advisory Committee docket number found in brackets in the Conference on Aging (WHCOA) through meetings. heading of this document. Received a half-day session with dementia- comments may be seen in the Division focused panels on each WHCOA topic II. Significance of Guidance of Dockets Management between 9 a.m. area: Healthy aging, long-term services This draft guidance is being issued and 4 p.m., Monday through Friday, and and supports, retirement security, and consistent with FDA’s good guidance will be posted to the docket at http:// elder justice. Following this session, the practices regulation (21 CFR 10.115). www.regulations.gov. Advisory Council will also hold a brief The draft guidance, when finalized, will discussion on the 2015 Update to the represent the Agency’s current thinking VI. References National Plan to Address Alzheimer’s, on the panel meeting process for The following references have been as well as a discussion of international medical devices. It does not create or placed on display in the Division of events on dementia. confer any rights for or on any person Dockets Management (see ADDRESSES), DATES: The meeting will be held on and does not operate to bind FDA or the and may be seen by interested persons April 28th, 2015 from 9:00 a.m. to 5:00 public. An alternative approach may be between 9 a.m. and 4 p.m., Monday p.m. EDT. used if such approach satisfies the through Friday, and are available ADDRESSES: The meeting will be held in requirements of the applicable statute electronically at http:// and regulations. Room 800 in the Hubert H. Humphrey www.regulations.gov. (FDA has verified Building, 200 Independence Avenue III. Electronic Access the Web site addresses, but we are not SW., Washington, DC 20201. responsible for any subsequent changes Comments: Time is allocated in the Persons interested in obtaining a copy to the Web sites after this document of the draft guidance may do so by afternoon on the agenda to hear public publishes in the Federal Register.) comments. The time for oral comments downloading an electronic copy from the Internet. A search capability for all 1. CDRH’s Medical Devices Advisory will be limited to two (2) minutes per CDRH guidance documents is available Committee, available at http://www.fda.gov/ individual. In lieu of oral comments, AdvisoryCommittees/ formal written comments may be at http://www.fda.gov/MedicalDevices/ CommitteesMeetingMaterials/ DeviceRegulationandGuidance/ submitted for the record to Rohini MedicalDevices/ GuidanceDocuments/default.htm. MedicalDevicesAdvisoryCommittee/ Khillan, OASPE, 200 Independence Guidance documents are also available default.htm. Avenue SW., Room 424E, Washington, at http://www.regulations.gov. Persons 2. ‘‘Guidance for Industry and FDA Staff: DC 20201. Comments may also be sent unable to download an electronic copy Guidance on Amended Procedures for to napa@hhs.gov. Those submitting Advisory Panel Meetings,’’ July 2000, written comments should identify mstockstill on DSK4VPTVN1PROD with NOTICES of ‘‘Procedures for Meetings of the Medical Devices Advisory Committee’’ available at http://www.fda.gov/downloads/ themselves and any relevant may send an email request to CDRH- MedicalDevices/ organizational affiliations. DeviceRegulationandGuidance/ Guidance@fda.hhs.gov to receive an GuidanceDocuments/ucm073726.pdf. FOR FURTHER INFORMATION CONTACT: electronic copy of the document. Please 3. ‘‘Panel Review of Premarket Approval Rohini Khillan (202) 690–5932, use the document number 413 to Applications #P91–2 (blue book memo),’’ rohini.khillan@hhs.gov. Note: Seating identify the guidance you are May 1991, available at http://www.fda.gov/ may be limited. Those wishing to attend requesting. MedicalDevices/ the meeting must send an email to VerDate Sep<11>2014 18:37 Mar 31, 2015 Jkt 235001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\01APN1.SGM 01APN1

Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 17441 napa@hhs.gov and put ‘‘April 28 Vitamin D External Quality Assessment provisions set forth in sections Meeting Attendance’’ in the Subject line Scheme (DEQAS), announce that as part 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., by Friday, April 17, so that their names of the Vitamin D Standardization as amended. The grant applications and may be put on a list of expected Program (VDSP), they are recruiting the discussions could disclose attendees and forwarded to the security laboratories to participate in a study of confidential trade secrets or commercial officers at the Department of Health and the commutability of pooled serum property such as patentable material, Human Services. Any interested samples used in assays to measure total and personal information concerning member of the public who is a non-U.S. 25-hydroxyvitamin D [25(OH)D]. individuals associated with the grant citizen should include this information DATES: The expected start date for the applications, the disclosure of which at the time of registration to ensure that study is June 2015. would constitute a clearly unwarranted the appropriate security procedure to ADDRESSES: For more information about invasion of personal privacy. gain entry to the building is carried out. the study and to let us know if you are Name of Committee: National Institute on Although the meeting is open to the interested in participating, please Aging Special Emphasis Panel; Fibroblast public, procedures governing security contact us at: vdsp@mail.nih.gov. Growth Factor And Aging. and the entrance to Federal buildings Date: May 1, 2015. FOR FURTHER INFORMATION CONTACT: Drs. may change without notice. If you wish Time: 1:00 p.m. to 5:00 p.m. Johanna Camara, NIST, and Christopher Agenda: To review and evaluate grant to make a public comment, you must Sempos, ODS, Director and Co-Director, applications. note that within your email. respectively, for the VDSP Place: National Institute on Aging, SUPPLEMENTARY INFORMATION: Notice of Commutability Study 2. Email: VDSP@ Gateway Building, Suite 2C212, 7201 these meetings is given under the mail.nih.gov. Wisconsin Avenue, Bethesda, MD 20892, Federal Advisory Committee Act (5 (Telephone Conference Call). SUPPLEMENTARY INFORMATION: The U.S.C. App. 2, section 10(a)(1) and Contact Person: Alicja L. Markowska, objective of the study is to promote the Ph.D., DSC., Scientific Review Branch, (a)(2)). Topics of the Meeting: The standardized measurement of total National Institute On Aging, 7201 Wisconsin Advisory Council will hear 25(OH)D by evaluating the Avenue, Suite 2c212, Bethesda, MD 20892, presentations on the basics of long-term commutability of NIST Standard 301–496–9666, markowsa@nia.nih.gov. care, including presentations on Reference Materials® (SRM) used as (Catalogue of Federal Domestic Assistance programs, settings, and payers. The ‘‘trueness’’ controls and the materials Program Nos. 93.866, Aging Research, Council will use a portion of the used in the major Performance Testing/ National Institutes of Health, HHS) meeting to review the work it has External Quality (PT/EQA) programs accomplished thus far towards the 2025 Dated: March 26, 2015. administered by CAP and DEQAS. Who goals, and then discuss the process for Melanie J. Gray, Can Participate: (1) All commercial developing recommendations for the Program Analyst, Office of Federal Advisory manufacturers of 25(OH)D assays 2015 update to the National Plan. The Committee Policy. (requests from manufacturers with Council will also hear presentations [FR Doc. 2015–07338 Filed 3–31–15; 8:45 am] assays in development will be from the three subcommittees (Research, considered); (2) Clinical and research BILLING CODE 4140–01–P Clinical Care, Long-Term Services and laboratories using a commercial assay Supports, and Ethics). Procedure and Agenda: This meeting platform; (3) Laboratories for national/ subnational nutrition surveys; and (4) DEPARTMENT OF HEALTH AND is open to the public. Please allow 30 HUMAN SERVICES minutes to go through security and walk Laboratories using in-house developed to the meeting room. The meeting will assays. National Institutes of Health For details about the study design and also be webcast at www.hhs.gov/live. time lines, see the recently published National Institute on Aging; Notice of Authority: 42 U.S.C. 11225; Section 2(e)(3) paper in the February 2015 edition of of the National Alzheimer’s Project Act. The Meeting Clinical Laboratory News, (https:// panel is governed by provisions of Public Pursuant to section 10(d) of the Law 92–463, as amended (5 U.S.C. Appendix www.aacc.org/publications/cln/articles/ 2015/february/vitamin-d- Federal Advisory Committee Act, as 2), which sets forth standards for the formation and use of advisory committees. commutability-study). amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board Dated: March 25, 2015. Dated: March 24, 2015. of Scientific Counselors, NIA. Richard G. Frank, Lawrence A. Tabak, The meeting will be open to the Assistant Secretary for Planning and Deputy Director, National Institutes of Health. public as indicated below, with Evaluation. [FR Doc. 2015–07326 Filed 3–31–15; 8:45 am] attendance limited to space available. [FR Doc. 2015–07374 Filed 3–31–15; 8:45 am] BILLING CODE 4140–01–P Individuals who plan to attend and BILLING CODE 4150–05–P need special assistance, such as sign language interpretation or other DEPARTMENT OF HEALTH AND reasonable accommodations, should DEPARTMENT OF HEALTH AND HUMAN SERVICES notify the Contact Person listed below HUMAN SERVICES in advance of the meeting. National Institutes of Health The meeting will be closed to the National Institutes of Health public as indicated below in accordance National Institute on Aging; Notice of mstockstill on DSK4VPTVN1PROD with NOTICES with the provisions set forth in section Office of Dietary Supplements VDSP Closed Meeting 552b(c)(6), Title 5 U.S.C., as amended Commutability Study 2 Pursuant to section 10(d) of the for the review, discussion, and SUMMARY: NIH Office of Dietary Federal Advisory Committee Act, as evaluation of individual intramural Supplements (ODS) and the National amended (5 U.S.C. App.), notice is programs and projects conducted by the Institute of Standards and Technology hereby given of the following meeting. NATIONAL INSTITUTE ON AGING, (NIST), in collaboration with the College The meeting will be closed to the including consideration of personnel of American Pathologists (CAP) and public in accordance with the qualifications and performance, and the VerDate Sep<11>2014 18:37 Mar 31, 2015 Jkt 235001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\01APN1.SGM 01APN1


Document Created: 2015-12-18 11:04:04
Document Modified: 2015-12-18 11:04:04
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe meeting will be held on April 28th, 2015 from 9:00 a.m. to 5:00 p.m. EDT.
ContactRohini Khillan (202) 690-5932, [email protected] Note: Seating may be limited. Those wishing to attend the meeting must send an email to [email protected] and put ``April 28 Meeting Attendance'' in the Subject line by Friday, April 17, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email.
FR Citation80 FR 17440 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR